Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

HBCC banner Human Brain Collection Core (HBCC)


Publications with HBCC Co-Authorship

Girdhar, K., et al. (2022). "Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains." Nature Neuroscience 25(4): 474-483.

Akula, N., et al. (2021). "Deep transcriptome sequencing of subgenual anterior cingulate cortex reveals cross-diagnostic and diagnosis-specific RNA expression changes in major psychiatric disorders." Neuropsychopharmacology 46(7): 1364-1372.

Gregory, M. D., et al. (2021). "Neanderthal-derived genetic variation in living humans relates to schizophrenia diagnosis, to psychotic symptom severity, and to dopamine synthesis." Am J Med Genet B Neuropsychiatr Genet 186(5): 329-338.

Gregory, M. D., et al. (2021). "Neanderthal-Derived Genetic Variation is Associated with Functional Connectivity in the Brains of Living Humans." Brain Connect 11(1): 38-44.

Hegarty, C. E., et al. (2021). "Polymorphism in the ZNF804A Gene and Variation in D1 and D2/D3 Dopamine Receptor Availability in the Healthy Human Brain: A Dual Positron Emission Tomography Study." Biol Psychiatry Cogn Neurosci Neuroimaging 9: S2451-9022(20)30377-3.

Liu, Q. R., et al. (2021). "Novel Human Insulin Isoforms and C alpha-Peptide Product in Islets of Langerhans and Choroid Plexus." Diabetes 70(12): 2947-2956.

Unroe, K. A., et al. (2021). "Perinatal SSRI Exposure Disrupts G Protein-coupled Receptor BAI3 in Developing Dentate Gyrus and Adult Emotional Behavior: Relevance to Psychiatric Disorders." Neuroscience 471: 32-50.

Publications Supported by HBCC Resources

Sudre, G., Gildea, D.E., Shastri, G.G. et al. (2022). “Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder.” Mol Psychiatry.

Sampath, V.P.; Singh, S.V.; Pelov, I.; Horesh, N.; Zannadeh, H.; Tirosh, O.; Erel, Y.; Lichtstein, D. (2022). “Vanadium in Bipolar Disorders—Reviving an Old Hypothesis.” Int. J. Mol. Sci. 23, 13901.

Jin, C., Lee, B., Shen, L., Long, Q., & (2022). “Alzheimer’s Disease Neuroimaging Initiative. Integrating multi-omics summary data using a Mendelian randomization framework.” Briefings in Bioinformatics 23:6

Vilor-Tejedor, N., & Guigo, R. (2022). “Brain transcriptomic profiling reveals common alterations across neurodegenerative and psychiatric disorders.”

Pourshafie, Naemeh, et al. (2022). “Altered SYNJ2BP-mediated mitochondrial-ER contacts in motor neuron disease.” Neurobiology of Disease 172: 105832.

Langston, Rebekah G., et al. (2022). “Association of a common genetic variant with Parkinson’s disease is mediated by microglia." Science Translational Medicine 14.655: eabp8869.

van den Oord, Edwin JCG, et al. (2022). "A single‐nucleus transcriptomics study of alcohol use disorder in the nucleus accumbens." Addiction Biology 28.1: e13250.

Al-Louzi, Omar, et al. (2022). "Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study." Multiple Sclerosis Journal: 13524585221097560.

Chen, R., Yang, Z., Liu, J. et al. (2022). “Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants.” Genome Med 14, 53.

Chand, G. B., et al. (2022). "Differential sphingosine-1-phosphate receptor-1 protein expression in the dorsolateral prefrontal cortex between schizophrenia Type 1 and Type 2." Frontiers in Psychiatry 13: 827981.          

Hoffman, G. E., et al. (2022). "Sex differences in the human brain transcriptome of cases with schizophrenia." Biological Psychiatry 91(1): 92-101.

Liao, C., et al. (2022). "Transcriptional patterns of coexpression across autism risk genes converge on established and novel signatures of neurodevelopment." medRxiv 2022.02.28.22271620.

Logan, R. W., et al. (2022). "Sex differences in molecular rhythms in the human cortex." Biological Psychiatry 91(1): 152-162.

Park, S. W., et al. (2022). "Differential expression of gene co-expression networks related to the mTOR signaling pathway in bipolar disorder." Translational Psychiatry 12(1): 1-11.

Dong, P., Hoffman, G.E., Apontes, P. et al. (2022). “Population-level variation in enhancer expression identifies disease mechanisms in the human brain.” Nat Genet 54, 1493–1503

Sey, N.Y.A., Hu, B., Iskhakova, M. et al. (2022). “Chromatin architecture in addiction circuitry identifies risk genes and potential biological mechanisms underlying cigarette smoking and alcohol use traits.” Mol Psychiatry 27, 3085–3094.